Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Moderate-intensity Rosuvastatin Plus Ezetimibe Versus High-intensity Rosuvastatin for Target LDL-C Goal Achievement in Patients With Recent Ischemic Stroke: a Randomized Clinical Trial

NCT03993236 is registered in ClinicalTrials.gov with Keun-Sik Hong as lead sponsor.

NCT NCT03993236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03993236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Moderate-intensity Rosuvastatin Plus Ezetimibe Versus High-intensity Rosuvastatin for Target LDL-C Goal Achievement in Patients With Recent Ischemic Stroke: a Randomized Clinical Trial
Lead sponsor
Keun-Sik Hong
Phase
Phase 4
Overall status
Completed
Start date
September 9, 2019
Completion date
September 27, 2021
Enrollment
584 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, ischemic